Company intelligence / Profile preview

HemeOnCall

Ownership: Private
Development stage: Commercial

Overview

HemeOnCall provides expert hematology and oncology consultations via telemedicine. The service specializes in managing blood disorders and cancers, with particular expertise in women’s health hematology, iron deficiency, clotting and bleeding issues, abnormal blood counts, CML/CLL, and immune thrombocytopenia. Management is primarily through remote consultation and oral medications where appropriate.

Therapeutic areas: OncologyHematology
Modalities: Non-pharmacological therapySmall molecule
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on HemeOnCall.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HemeOnCall.

Explore the full profile